Works matching DE "ABACAVIR"

Results: 229
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Abacavir Induces Arterial Thrombosis in a Murine Model.

    Published in:
    2018
    By:
    • Collado-Diaz, Victor;
    • Andujar, Isabel;
    • Sanchez-Lopez, Ainhoa;
    • Orden, Samuel;
    • Blanch-Ruiz, María Amparo;
    • Martinez-Cuesta, María Angeles;
    • Blas-García, Ana;
    • Esplugues, Juan V.;
    • Álvarez, Ángeles
    Publication type:
    journal article
    11
    12

    Abacavir/Lamivudine Versus Tenofovir DF/ Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results.

    Published in:
    Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1191, doi. 10.1093/infdis/jir505
    By:
    • Sax, Paul E.;
    • Tierney, Camlin;
    • Collier, Ann C.;
    • Daar, Eric S.;
    • Mollan, Katie;
    • Budhathoki, Chakra;
    • Godfrey, Catherine;
    • Jahed, Nasreen C.;
    • Myers, Laurie;
    • Katzenstein, David;
    • Farajallah, Awny;
    • Rooney, James F.;
    • Ha, Belinda;
    • Woodward, William C.;
    • Feinberg, Judith;
    • Tashima, Karen;
    • Murphy, Robert L.;
    • Fischl, Margaret A.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Abacavir use is associated with increased prothrombin conversion.

    Published in:
    Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1182942
    By:
    • Qiuting Yan;
    • Shengshi Huang;
    • van der Heijden, Wouter;
    • Ninivaggi, Marisa;
    • van de Wijer, Lisa;
    • de Laat-Kremers, Romy;
    • Van der Ven, Andre J.;
    • de Laat, Bas;
    • de Mast, Quirijn
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

    Published in:
    Nature, 2012, v. 486, n. 7404, p. 554, doi. 10.1038/nature11147
    By:
    • Illing, Patricia T.;
    • Vivian, Julian P.;
    • Dudek, Nadine L.;
    • Kostenko, Lyudmila;
    • Chen, Zhenjun;
    • Bharadwaj, Mandvi;
    • Miles, John J.;
    • Kjer-Nielsen, Lars;
    • Gras, Stephanie;
    • Williamson, Nicholas A.;
    • Burrows, Scott R.;
    • Purcell, Anthony W.;
    • Rossjohn, Jamie;
    • McCluskey, James
    Publication type:
    Article
    43

    Impact of the Data Collection on Adverse Events of Anti-HIV Drugs Cohort Study on Abacavir Prescription among Treatment-Naive, HIV-Infected Patients in Canada.

    Published in:
    Journal of the International Association of Providers of AIDS Care, 2014, v. 13, n. 2, p. 153, doi. 10.1177/2325957413495565
    By:
    • Antoniou, Tony;
    • Gillis, Jennifer;
    • Loutfy, Mona R.;
    • Cooper, Curtis;
    • Hogg, Robert S.;
    • Klein, Marina B.;
    • Machouf, Nima;
    • Montaner, Julio S. G.;
    • Rourke, Sean B.;
    • Tsoukas, Chris;
    • Raboud, Janet M.
    Publication type:
    Article
    44
    45
    46
    47

    Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).

    Published in:
    Patient Preference & Adherence, 2022, v. 16, p. 3267, doi. 10.2147/PPA.S379065
    By:
    • Klein, Marina B;
    • Young, Jim;
    • Ortiz-Paredes, David;
    • Wang, Shouao;
    • Walmsley, Sharon;
    • Wong, Alexander;
    • Martel-Laferrière, Valérie;
    • Pick, Neora;
    • Conway, Brian;
    • Angel, Jonathan;
    • Baril, Jean-Guy;
    • Fraser, Chris;
    • Lebouché, Bertrand;
    • Tan, Darrell HS;
    • Sandre, Roger;
    • Trottier, Sylvie;
    • Peiris, Hansi;
    • Jayaraman, Jayamarx;
    • Singer, Joel
    Publication type:
    Article
    48

    First-line antiretroviral drug discontinuations in children.

    Published in:
    PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0169762
    By:
    • Fortuin-de Smidt, Melony;
    • de Waal, Reneé;
    • Cohen, Karen;
    • Technau, Karl-Günter;
    • Stinson, Kathryn;
    • Maartens, Gary;
    • Boulle, Andrew;
    • Igumbor, Ehimario U.;
    • Davies, Mary-Ann
    Publication type:
    Article
    49

    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Published in:
    PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164455
    By:
    • Troya, Jesús;
    • Ryan, Pablo;
    • Ribera, Esteban;
    • Podzamczer, Daniel;
    • Hontañón, Victor;
    • Terrón, Jose Alberto;
    • Boix, Vicente;
    • Moreno, Santiago;
    • Barrufet, Pilar;
    • Castaño, Manuel;
    • Carrero, Ana;
    • Galindo, María José;
    • Suárez-Lozano, Ignacio;
    • Knobel, Hernando;
    • Raffo, Miguel;
    • Solís, Javier;
    • Yllescas, María;
    • Esteban, Herminia;
    • González-García, Juan;
    • Berenguer, Juan
    Publication type:
    Article
    50